Skip to content
PubMed This is a summary of 37 peer-reviewed journal articles Updated
Maternal-Fetal Medicine · Trisomy 18

Starting Your Journey with Trisomy 18

At a Glance

Trisomy 18 is a genetic condition caused by an extra chromosome 18, and its effects vary widely. After diagnosis, families can confirm testing, meet specialists, understand possible interventions, and combine palliative support with care that reflects their child’s needs and family goals.

Receiving a diagnosis of Trisomy 18—whether during pregnancy or after your baby is born—is often a moment of profound emotional shock. You may have been given information that feels final or overwhelming, and it is common to feel as though the future you imagined has shifted instantly. This page is designed to help you navigate those first steps, providing a foundation of modern medical understanding to help you advocate for your child and your family. If you received a prenatal diagnosis, your most pressing next steps are confirming the result with diagnostic testing and meeting with a maternal-fetal medicine specialist to plan your delivery.

It is important to know that Trisomy 18 is almost always caused by a random error in cell division. It is not caused by anything a parent did or did not do, and you are not to blame.

Defining Trisomy 18

Trisomy 18, also known as Edwards syndrome, is a genetic condition that occurs when a child has three copies of chromosome 18 in some or all of their cells, instead of the usual two [1][2][3]. Chromosomes are the “instruction manuals” for the body, and having an extra set of instructions for chromosome 18 affects how a baby develops and grows [4][5][6].

There are three main types of Trisomy 18:

  • Full Trisomy 18: The extra chromosome is present in nearly all cells tested. This is the most common form [1][2][3].
  • Mosaic Trisomy 18: The extra chromosome is present in only some cells, while others have the typical two copies [1][2][3].
  • Partial Trisomy 18: Only a segment of chromosome 18 is tripled, often from an unbalanced chromosome rearrangement, rather than the entire chromosome [1][2][3]. This may be present in all or some cells.

Understanding the Rarity

Trisomy 18 is considered a rare condition. While estimates vary depending on the study and the region, it occurs in approximately 1 in every 3,000 to 8,000 live births [7][8][2]. Because it is uncommon, many local doctors or smaller hospitals may have limited direct experience with the condition [9][10]. You may find yourself in the position of seeking out specialists at larger academic medical centers who have more extensive experience in managing the complex needs associated with this diagnosis.

The Shift Away from “Incompatible with Life”

In the past, Trisomy 18 was frequently labeled “incompatible with life” or “lethally” by the medical community. However, modern medical consensus has shifted significantly away from using these absolute terms [11][12][13][14][15].

Current ethical and clinical guidelines emphasize that:

  • Survival is possible: While Trisomy 18 is associated with high mortality in the first year of life, some children survive into childhood and even adolescence [16][17][17].
  • Individualized care is essential: Decisions about medical care should be based on your child’s specific health needs and your family’s goals, rather than the genetic label alone [14][12][15].
  • Shared decision-making: You are an essential part of the care team. Doctors are increasingly encouraged to work with parents in a shared decision-making process—a collaborative approach where medical evidence is combined with your family’s values to choose the best path forward [18][19][14][12][15].

Knowns and Unknowns

When you first receive a diagnosis, there are things research can tell us and things that remain uncertain for every individual child.

What research tells us (The Knowns):

  • Multisystem Involvement: Trisomy 18 typically affects multiple organs. About 80% of liveborn infants have a congenital heart defect (a structural problem with the heart), and many also have challenges with breathing, feeding, or kidney function [7][20][21][5][22].
  • High Early Mortality: Statistically, the risk of pregnancy loss or death in the first weeks of life is high [23][24][25][16].
  • Developmental Delays: Children who survive beyond infancy will experience significant delays in reaching milestones, though their specific abilities vary [6][26][27].

What remains uncertain (The Unknowns):

  • Individual Trajectory: Statistics cannot predict the exact path for your specific child. Outcomes vary widely based on which organs are affected and how severely [28][24].
  • Impact of Interventions: In the past, many life-prolonging treatments were withheld from children with Trisomy 18. Newer research suggests that interventions like heart surgery or intensive care can improve survival for some children, though these choices come with significant medical burdens [29][16][30][31].
  • The Role of Mosaicism: If your child has the mosaic form, the percentage of extra chromosomes found in a blood test does not always accurately predict how their organs will function or how they will develop [32][33][34][35].

Palliative Care and Medical Intervention

It is a common misconception that choosing palliative care (specialized medical care focused on relief from symptoms and stress) means giving up on life-prolonging treatment. In modern medicine, these two approaches are not mutually exclusive [13][36][11][37].

Palliative care can be an “extra layer of support” that works alongside active medical treatments [13][36][11]. They can help manage pain, assist with difficult decisions, and focus on the quality of life for your child and your entire family, regardless of whether you choose to pursue intensive surgeries or comfort-focused care [13][11][12][37]. Integrating these supports early can help ensure that your child’s care plan remains responsive to their needs and your family’s evolving goals [13][36][11][12][15].

Common questions in this guide

What is Trisomy 18, also called Edwards syndrome?
Trisomy 18 is a genetic condition in which a child has three copies of chromosome 18 in some or all of the body’s cells instead of two. The extra chromosome can affect several organs, growth, and development, and its effects vary between children.
Did something cause my child’s Trisomy 18?
In almost every case, Trisomy 18 results from a random error when cells divide. It is not caused by something a parent did or did not do, and parents should not blame themselves.
What are the full, mosaic, and partial forms of Trisomy 18?
Full Trisomy 18 means the extra chromosome is found in nearly all cells tested. Mosaic Trisomy 18 means it is found in only some cells, while partial Trisomy 18 involves an extra segment of chromosome 18. The percentage seen in a blood test does not always predict how a child’s organs or development will be affected.
What should we do after a prenatal Trisomy 18 diagnosis?
Ask the care team whether diagnostic testing is needed to confirm the result, and request a consultation with a maternal-fetal medicine specialist. This team can review the findings, discuss delivery planning, and help you understand possible care options for your baby.
Can a baby or child with Trisomy 18 survive?
Trisomy 18 carries a high risk of pregnancy loss and death during the first year, but some children survive into childhood and adolescence. An individual outlook depends on the organs affected and the severity of their medical problems, so population statistics cannot predict exactly what will happen for one child.
Does choosing palliative care mean stopping all treatment?
No. Palliative care can be provided alongside surgery, intensive care, or other treatments that aim to prolong life. It also helps relieve symptoms, support decision-making, and focus on quality of life for the child and family.
How can parents make care decisions for a child with Trisomy 18?
Care decisions should consider the child’s specific health needs, the likely benefits and burdens of each intervention, and the family’s goals and values. Shared decision-making means parents and clinicians review the evidence together and reassess the plan as the child’s condition changes.

Get notified when new evidence is published on Trisomy 18 syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (37)
  1. 1

    [Mosaic trisomy 18. Series of cases].

    Cammarata-Scalisi F, Lacruz-Rengel MA, Araque D, et al.

    Archivos argentinos de pediatria 2017; (115(3)):e183-e186 doi:10.5546/aap.2017.e183.

    PMID: 28504507
  2. 2

    A visual tool inclusive of fetal ultrasound and autopsy findings to reach a balanced approach to counseling on trisomy 18 in early second trimester.

    Triunfo S, Bonollo M, Gaffuri P, et al.

    Archives of gynecology and obstetrics 2021; (304(5)):1115-1125 doi:10.1007/s00404-021-06130-7.

    PMID: 34159403
  3. 3

    A Case of a Derivative Chromosome: der(Y)t(Y;18)Pat with Congenital Abnormalities.

    Huang S, Xia Y, Ding H, et al.

    Fetal and pediatric pathology 2021; (40(3)):256-261 doi:10.1080/15513815.2019.1695297.

    PMID: 31805817
  4. 4

    Prenatal phenotypic spectrum of full trisomy 18 in an Indian cohort.

    Sandal S, Mahay SB, Dimri Gupta N, et al.

    American journal of medical genetics. Part A 2022; (188(6)):1904-1908 doi:10.1002/ajmg.a.62692.

    PMID: 35191187
  5. 5

    Prenatal echocardiography in Trisomy 18 - the key to diagnosis and further management in the second half of pregnancy.

    Nowakowska A, Sylwestrzak O, Strzelecka I, et al.

    Ginekologia polska 2023; (94(5)):366-373 doi:10.5603/GP.a2023.0035.

    PMID: 37070966
  6. 6

    Developmental status of 22 children with trisomy 18 and eight children with trisomy 13: implications and recommendations.

    Bruns DA

    American journal of medical genetics. Part A 2015; (167A(8)):1807-15 doi:10.1002/ajmg.a.37102.

    PMID: 25847310
  7. 7

    Congenital anomalies associated with trisomy 18 or trisomy 13: A registry-based study in 16 European countries, 2000-2011.

    Springett A, Wellesley D, Greenlees R, et al.

    American journal of medical genetics. Part A 2015; (167A(12)):3062-9 doi:10.1002/ajmg.a.37355.

    PMID: 26347425
  8. 8

    Strawberry skull in Edwards syndrome.

    Mudaliyar US, Mudaliyar SU

    BJR case reports 2017; (3(4)):20170045 doi:10.1259/bjrcr.20170045.

    PMID: 30363185
  9. 9

    Prevalence and diagnostic dilemma of chromosomal abnormalities in the Niger Delta area of Nigeria; Is prenatal diagnosis worthwhile?

    Abbey M, West BA, Amadi SC, et al.

    Nigerian medical journal : journal of the Nigeria Medical Association 2025; (66(1)):60-69 doi:10.71480/nmj.v66i1.561.

    PMID: 40309537
  10. 10

    Trisomy 13 and 18-Prevalence and mortality-A multi-registry population based analysis.

    Goel N, Morris JK, Tucker D, et al.

    American journal of medical genetics. Part A 2019; (179(12)):2382-2392 doi:10.1002/ajmg.a.61365.

    PMID: 31566869
  11. 11

    Trisomy 18-when the diagnosis is compatible with life.

    Silva C, Ferreira MC, Saraiva J, Cancelinha C

    European journal of pediatrics 2022; (181(7)):2809-2819 doi:10.1007/s00431-022-04477-w.

    PMID: 35522316
  12. 12

    Guidance for Caring for Infants and Children With Trisomy 13 and Trisomy 18: Clinical Report.

    Pyle AK, George TN, Cummings JJ, et al.

    Pediatrics 2025; (156(2)) doi:10.1542/peds.2025-072719.

    PMID: 40685149
  13. 13

    Cardiac Interventions for Patients With Trisomy 13 and Trisomy 18: Experience, Ethical Issues, Communication, and the Case for Individualized Family-Centered Care.

    Cleary JP, Janvier A, Farlow B, et al.

    World journal for pediatric & congenital heart surgery 2022; (13(1)):72-76 doi:10.1177/21501351211044132.

    PMID: 34919485
  14. 14

    The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Recommendation for the care of children with trisomy 13 or trisomy 18 and a congenital heart defect.

    St Louis JD, Bhat A, Carey JC, et al.

    The Journal of thoracic and cardiovascular surgery 2024; (167(5)):1519-1532 doi:10.1016/j.jtcvs.2023.11.054.

    PMID: 38284966
  15. 15

    Structured Framework for Multidisciplinary Parent Counseling and Medical Interventions for Fetuses and Infants with Trisomy 13 or Trisomy 18.

    Kim AJH, Marshall M, Gievers L, et al.

    American journal of perinatology 2024; (41(S 01)):e2666-e2673 doi:10.1055/s-0043-1772748.

    PMID: 37619598
  16. 16

    Survival and Surgical Interventions for Children With Trisomy 13 and 18.

    Nelson KE, Rosella LC, Mahant S, Guttmann A

    JAMA 2016; (316(4)):420-8 doi:10.1001/jama.2016.9819.

    PMID: 27458947
  17. 17

    Long-Term Survival Among Children With Trisomy 13 and Trisomy 18 by Cytogenetic Status.

    Ludorf KL, Benjamin RH, Shumate CJ, et al.

    JAMA network open 2025; (8(9)):e2529885 doi:10.1001/jamanetworkopen.2025.29885.

    PMID: 40920381
  18. 18

    Shared decision making and the pathways approach in the prenatal and postnatal management of the trisomy 13 and trisomy 18 syndromes.

    Andrews SE, Downey AG, Showalter DS, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2016; (172(3)):257-63 doi:10.1002/ajmg.c.31524.

    PMID: 27557275
  19. 19

    Using Patient-Centered Care After a Prenatal Diagnosis of Trisomy 18 or Trisomy 13: A Review.

    Haug S, Goldstein M, Cummins D, et al.

    JAMA pediatrics 2017; (171(4)):382-387 doi:10.1001/jamapediatrics.2016.4798.

    PMID: 28192554
  20. 20

    An analysis of cardiac defects and surgical interventions in 84 cases with full trisomy 18.

    Bruns DA, Martinez A

    American journal of medical genetics. Part A 2016; (170A(2)):337-343 doi:10.1002/ajmg.a.37427.

    PMID: 26453443
  21. 21

    Wilms Tumor in Child With Trisomy 18 and Horseshoe Kidney.

    Chen E, Hackney L, VanHeyst K, Miyasaka EA

    Journal of pediatric hematology/oncology 2023; (45(8)):e1018-e1022 doi:10.1097/MPH.0000000000002756.

    PMID: 37749779
  22. 22

    Anatomy of trisomy 18.

    Roberts W, Zurada A, Zurada-ZieliŃSka A, et al.

    Clinical anatomy (New York, N.Y.) 2016; (29(5)):628-32 doi:10.1002/ca.22725.

    PMID: 27087248
  23. 23

    Revised estimates of the risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18.

    Cavadino A, Morris JK

    American journal of medical genetics. Part A 2017; (173(4)):953-958 doi:10.1002/ajmg.a.38123.

    PMID: 28328132
  24. 24

    Poorer survival in prenatally diagnosed trisomy 18 infants compared with postnatally diagnosed cases: a single-center study.

    Koshida S, Takahashi K

    PeerJ 2026; (14()):e21515 doi:10.7717/peerj.21515.

    PMID: 42437037
  25. 25

    Ten-year survival of children with trisomy 13 or trisomy 18: a multi-registry European cohort study.

    Glinianaia SV, Rankin J, Tan J, et al.

    Archives of disease in childhood 2023; (108(6)):461-467 doi:10.1136/archdischild-2022-325068.

    PMID: 36882305
  26. 26

    Characterization of a 16-Year-Old Long-Time Survivor of Edwards Syndrome.

    Khan F, Jafri I

    Cureus 2021; (13(5)):e15205 doi:10.7759/cureus.15205.

    PMID: 34178525
  27. 27

    Factors related to survival discharge in trisomy 18: A retrospective multicenter study.

    Kato E, Kitase Y, Tachibana T, et al.

    American journal of medical genetics. Part A 2019; (179(7)):1253-1259 doi:10.1002/ajmg.a.61146.

    PMID: 30942556
  28. 28

    Neonatal Hospital Course and Outcomes of Live-born Infants with Trisomy 18 at Two Tertiary Care Centers in the United States.

    Dereddy NR, Pivnick EK, Upadhyay K, et al.

    American journal of perinatology 2017; (34(3)):270-275 doi:10.1055/s-0036-1586753.

    PMID: 27490773
  29. 29

    Significant improvement in survival outcomes of trisomy 18 with neonatal intensive care compared to non-intensive care: a single-center study.

    Koshida S, Takahashi K

    PeerJ 2023; (11()):e16537 doi:10.7717/peerj.16537.

    PMID: 38047023
  30. 30

    Outcomes of heart surgery in neonates with trisomy 13 and 18: a systematic review with metanalysis.

    de Sá Bittencourt Câmara Bastos C, Vale da Cruz L, Hirano Arruda Moraes L, et al.

    European journal of pediatrics 2025; (184(7)):430 doi:10.1007/s00431-025-06274-7.

    PMID: 40537699
  31. 31

    Operative and nonoperative outcomes in patients with trisomy 13 and 18 with congenital heart disease.

    Greene CL, Schulz A, Chávez M, et al.

    JTCVS open 2024; (20()):123-131 doi:10.1016/j.xjon.2024.06.007.

    PMID: 39296445
  32. 32

    Phenotypic Spectrum of Trisomy 18 Mosaicism: a New Patient and Literature Review.

    Sun W, Wang L, Liu T, et al.

    Clinical laboratory 2023; (69(3)) doi:10.7754/Clin.Lab.2022.220610.

    PMID: 36912299
  33. 33

    Phenotypic extremes in liveborn monozygotic twins with mosaic Edwards syndrome.

    Bussmann N, Cunningham K, Green A, Ryan CA

    BMJ case reports 2015; (2015()).

    PMID: 26561224
  34. 34

    Prenatal diagnosis of mosaic trisomy 18 and maternal uniparental disomy 18 by amniocentesis in a pregnancy associated with cytogenetic discrepancy in various tissues and a favorable fetal outcome.

    Chen CP, Wu FT, Pan YT, et al.

    Taiwanese journal of obstetrics & gynecology 2023; (62(4)):606-610 doi:10.1016/j.tjog.2023.05.012.

    PMID: 37407205
  35. 35

    Cytogenetic discrepancy between uncultured amniocytes and cultured amniocytes in mosaic trisomy 18 at amniocentesis in a pregnancy with a favorable fetal outcome and maternal uniparental disomy 18.

    Chen CP, Su JW, Chern SR, et al.

    Taiwanese journal of obstetrics & gynecology 2022; (61(4)):684-689 doi:10.1016/j.tjog.2022.05.005.

    PMID: 35779922
  36. 36

    Transitions in Care for Infants with Trisomy 13 or 18.

    Patterson J, Taylor G, Smith M, et al.

    American journal of perinatology 2017; (34(9)):887-894 doi:10.1055/s-0037-1600912.

    PMID: 28301894
  37. 37

    Experiences of children with trisomy 18 referred to pediatric palliative care services on two continents.

    Mullin J, Wolfe J, Bluebond-Langner M, Craig F

    American journal of medical genetics. Part A 2019; (179(6)):903-907 doi:10.1002/ajmg.a.61149.

    PMID: 30932336

This page is for informational purposes only and does not constitute medical advice. Your child’s healthcare team can interpret the diagnosis and discuss care choices based on your child’s needs and your family’s goals.